Shuttle Pharmaceuticals ... (SHPH)
undefined
undefined%
At close: undefined
0.68
0.35%
After-hours Dec 13, 2024, 06:21 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY18 FY17
Revenue - - - - - -
Cost of Revenue 6.81K 66.83K 60.83K 54.95K 18.00K 18.74K
Gross Profit -6.81K -66.83K -60.83K -54.95K -18.00K -18.74K
Operating Income -5.89M -2.55M -1.74M -509.52K -586.63K -203.89K
Interest Income 79.12K - - - - -
Pretax Income -6.59M -3.03M -1.15M -805.73K -626.14K -213.59K
Net Income -6.59M -3.10M -1.20M -845.36K -626.14K -213.59K
Selling & General & Admin 1.05M 1.07M 721.18K 347.75K 513.06K 185.99K
Research & Development 3.52M 1.49M 1.02M 161.77K 55.57K -836
Other Expenses 1.33M 328.69K - - - -
Operating Expenses 5.89M 2.55M 1.74M 509.52K 568.63K 185.15K
Interest Expense 2.60M 969.89K 50.79K 39.63K 30.92K 10.88K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 5.89M 2.55M 1.74M 509.52K 586.63K 203.89K
Income Tax - 71.01K 50.79K 39.63K - 1.00
Shares Outstanding (Basic) 15.91M 10.35M 13.59M 13.59M 13.59M 13.59M
Shares Outstanding (Diluted) 15.91M 10.35M 13.59M 13.59M 13.59M 13.59M
EPS (Basic) -0.41 -0.3 -0.09 -0.06 -0.05 -0.02
EPS (Diluted) -0.41 -0.3 -0.09 -0.06 -0.05 -0.02
EBITDA -3.99M -4.32M -1.04M -711.15K -577.22K -183.97K
Depreciation & Amortization 6.81K 5.97K 60.83K 54.95K 18.00K 18.74K